2022-01-272023-01-312023-01-31falseSC721137ABERDEEN HEALTHCARE LIMITED2023-10-2564209iso4217:GBPxbrli:pureSC7211372022-01-27SC7211372023-01-31SC7211372022-01-272023-01-31SC7211372022-01-26SC7211372022-01-26SC7211372022-01-262022-01-26SC721137bus:SmallEntities2022-01-272023-01-31SC721137bus:AuditExempt-NoAccountantsReport2022-01-272023-01-31SC721137bus:AbridgedAccounts2022-01-272023-01-31SC721137bus:PrivateLimitedCompanyLtd2022-01-272023-01-31SC721137core:WithinOneYear2023-01-31SC721137core:AfterOneYear2023-01-31SC721137core:WithinOneYear2022-01-26SC721137core:AfterOneYear2022-01-26SC721137core:ShareCapital2023-01-31SC721137core:SharePremium2023-01-31SC721137core:RevaluationReserve2023-01-31SC721137core:OtherReservesSubtotal2023-01-31SC721137core:RetainedEarningsAccumulatedLosses2023-01-31SC721137core:ShareCapital2022-01-26SC721137core:SharePremium2022-01-26SC721137core:RevaluationReserve2022-01-26SC721137core:OtherReservesSubtotal2022-01-26SC721137core:RetainedEarningsAccumulatedLosses2022-01-26SC721137core:LandBuildings2023-01-31SC721137core:PlantMachinery2023-01-31SC721137core:Vehicles2023-01-31SC721137core:FurnitureFittings2023-01-31SC721137core:OfficeEquipment2023-01-31SC721137core:NetGoodwill2023-01-31SC721137core:IntangibleAssetsOtherThanGoodwill2023-01-31SC721137core:ListedExchangeTraded2023-01-31SC721137core:UnlistedNon-exchangeTraded2023-01-31SC721137core:LandBuildings2022-01-26SC721137core:PlantMachinery2022-01-26SC721137core:Vehicles2022-01-26SC721137core:FurnitureFittings2022-01-26SC721137core:OfficeEquipment2022-01-26SC721137core:NetGoodwill2022-01-26SC721137core:IntangibleAssetsOtherThanGoodwill2022-01-26SC721137core:ListedExchangeTraded2022-01-26SC721137core:UnlistedNon-exchangeTraded2022-01-26SC721137core:LandBuildings2022-01-272023-01-31SC721137core:PlantMachinery2022-01-272023-01-31SC721137core:Vehicles2022-01-272023-01-31SC721137core:FurnitureFittings2022-01-272023-01-31SC721137core:OfficeEquipment2022-01-272023-01-31SC721137core:NetGoodwill2022-01-272023-01-31SC721137core:IntangibleAssetsOtherThanGoodwill2022-01-272023-01-31SC721137core:ListedExchangeTraded2022-01-272023-01-31SC721137core:UnlistedNon-exchangeTraded2022-01-272023-01-31SC721137core:MoreThanFiveYears2022-01-272023-01-31SC721137core:Non-currentFinancialInstruments2023-01-31SC721137core:Non-currentFinancialInstruments2022-01-26SC721137dpl:CostSales2022-01-272023-01-31SC721137dpl:DistributionCosts2022-01-272023-01-31SC721137dpl:AdministrativeExpenses2022-01-272023-01-31SC721137core:LandBuildings2022-01-272023-01-31SC721137core:PlantMachinery2022-01-272023-01-31SC721137core:Vehicles2022-01-272023-01-31SC721137core:FurnitureFittings2022-01-272023-01-31SC721137core:OfficeEquipment2022-01-272023-01-31SC721137core:NetGoodwill2022-01-272023-01-31SC721137core:IntangibleAssetsOtherThanGoodwill2022-01-272023-01-31SC721137dpl:GroupUndertakings2022-01-272023-01-31SC721137dpl:ParticipatingInterests2022-01-272023-01-31SC721137dpl:GroupUndertakingscore:ListedExchangeTraded2022-01-272023-01-31SC721137core:ListedExchangeTraded2022-01-272023-01-31SC721137dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-01-272023-01-31SC721137core:UnlistedNon-exchangeTraded2022-01-272023-01-31SC721137dpl:CostSales2022-01-262022-01-26SC721137dpl:DistributionCosts2022-01-262022-01-26SC721137dpl:AdministrativeExpenses2022-01-262022-01-26SC721137core:LandBuildings2022-01-262022-01-26SC721137core:PlantMachinery2022-01-262022-01-26SC721137core:Vehicles2022-01-262022-01-26SC721137core:FurnitureFittings2022-01-262022-01-26SC721137core:OfficeEquipment2022-01-262022-01-26SC721137core:NetGoodwill2022-01-262022-01-26SC721137core:IntangibleAssetsOtherThanGoodwill2022-01-262022-01-26SC721137dpl:GroupUndertakings2022-01-262022-01-26SC721137dpl:ParticipatingInterests2022-01-262022-01-26SC721137dpl:GroupUndertakingscore:ListedExchangeTraded2022-01-262022-01-26SC721137core:ListedExchangeTraded2022-01-262022-01-26SC721137dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-01-262022-01-26SC721137core:UnlistedNon-exchangeTraded2022-01-262022-01-26SC721137core:NetGoodwill2023-01-31SC721137core:IntangibleAssetsOtherThanGoodwill2023-01-31SC721137core:LandBuildings2023-01-31SC721137core:PlantMachinery2023-01-31SC721137core:Vehicles2023-01-31SC721137core:FurnitureFittings2023-01-31SC721137core:OfficeEquipment2023-01-31SC721137core:AfterOneYear2023-01-31SC721137core:WithinOneYear2023-01-31SC721137core:ListedExchangeTraded2023-01-31SC721137core:UnlistedNon-exchangeTraded2023-01-31SC721137core:ShareCapital2023-01-31SC721137core:SharePremium2023-01-31SC721137core:RevaluationReserve2023-01-31SC721137core:OtherReservesSubtotal2023-01-31SC721137core:RetainedEarningsAccumulatedLosses2023-01-31SC721137core:NetGoodwill2022-01-26SC721137core:IntangibleAssetsOtherThanGoodwill2022-01-26SC721137core:LandBuildings2022-01-26SC721137core:PlantMachinery2022-01-26SC721137core:Vehicles2022-01-26SC721137core:FurnitureFittings2022-01-26SC721137core:OfficeEquipment2022-01-26SC721137core:AfterOneYear2022-01-26SC721137core:WithinOneYear2022-01-26SC721137core:ListedExchangeTraded2022-01-26SC721137core:UnlistedNon-exchangeTraded2022-01-26SC721137core:ShareCapital2022-01-26SC721137core:SharePremium2022-01-26SC721137core:RevaluationReserve2022-01-26SC721137core:OtherReservesSubtotal2022-01-26SC721137core:RetainedEarningsAccumulatedLosses2022-01-26SC721137core:NetGoodwill2022-01-26SC721137core:IntangibleAssetsOtherThanGoodwill2022-01-26SC721137core:LandBuildings2022-01-26SC721137core:PlantMachinery2022-01-26SC721137core:Vehicles2022-01-26SC721137core:FurnitureFittings2022-01-26SC721137core:OfficeEquipment2022-01-26SC721137core:AfterOneYear2022-01-26SC721137core:WithinOneYear2022-01-26SC721137core:ListedExchangeTraded2022-01-26SC721137core:UnlistedNon-exchangeTraded2022-01-26SC721137core:ShareCapital2022-01-26SC721137core:SharePremium2022-01-26SC721137core:RevaluationReserve2022-01-26SC721137core:OtherReservesSubtotal2022-01-26SC721137core:RetainedEarningsAccumulatedLosses2022-01-26SC721137core:AfterOneYear2022-01-272023-01-31SC721137core:WithinOneYear2022-01-272023-01-31SC721137core:Non-currentFinancialInstrumentscore:CostValuation2022-01-272023-01-31SC721137core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-01-272023-01-31SC721137core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-01-272023-01-31SC721137core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-01-272023-01-31SC721137core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-01-272023-01-31SC721137core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-01-272023-01-31SC721137core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-01-272023-01-31SC721137core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-01-272023-01-31SC721137core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-01-272023-01-31SC721137core:Non-currentFinancialInstrumentscore:CostValuation2023-01-31SC721137core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-31SC721137core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-31SC721137core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-31SC721137core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-31SC721137core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-31SC721137core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-31SC721137core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-31SC721137core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-31SC721137core:Non-currentFinancialInstrumentscore:CostValuation2022-01-26SC721137core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-01-26SC721137core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-01-26SC721137core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-01-26SC721137core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-01-26SC721137core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-01-26SC721137core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-01-26SC721137core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-01-26SC721137core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-01-26SC721137bus:Director12022-01-272023-01-31SC721137bus:Director22022-01-272023-01-31

ABERDEEN HEALTHCARE LIMITED

Registered Number
SC721137
(Scotland)

Unaudited Financial Statements for the Period ended
31 January 2023

ABERDEEN HEALTHCARE LIMITED
Company Information
for the period from 27 January 2022 to 31 January 2023

Directors

MOHAMMED, Ahdul
NASSAR, Ahmad Karim

Company Secretary

NASSAR, Ahmad Karim

Registered Address

77 Dunn Street
Glasgow
G40 3PA

Registered Number

SC721137 (Scotland)
ABERDEEN HEALTHCARE LIMITED
Balance Sheet as at
31 January 2023

Notes

2023

£

£

Fixed assets
Investments51,376,654
1,376,654
Current assets
Debtors2
2
Net current assets (liabilities)2
Total assets less current liabilities1,376,656
Net assets1,376,656
Capital and reserves
Called up share capital1,376,656
Shareholders' funds1,376,656
The financial statements were approved and authorised for issue by the Board of Directors on 25 October 2023, and are signed on its behalf by:
MOHAMMED, Ahdul
Director
NASSAR, Ahmad Karim
Director

Registered Company No. SC721137
ABERDEEN HEALTHCARE LIMITED
Notes to the Financial Statements
for the period ended 31 January 2023

1.Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Investments policy
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
4.Employee information

2023
Average number of employees during the year2
5.Fixed asset investments
The investment of £1,376,654 is related to acquisition of Mount Street (Aberdeen) Limited.

Total

£
Cost or valuation
Additions1,376,654
At 31 January 231,376,654
Net book value
At 31 January 231,376,654
At 26 January 22-